ProGenTech gains $21M in third venture round

ProGenTech, with operations in California and China, has pocketed $21 million in its third round of venture financing. The biotech company markets products for research and medical diagnostics and is developing a contamination free, cassette based automated nucleic acid purification system. Bay City Capital and DT Capital led the round. ProGenTech was founded by two engineers: Steve Yu and Jesus Ching. Yu will remain a director of the company and become its president and COO. Ching will become the chief scientific officer of ProGenTech.

- check out the press release